{"id":"NCT01813422","sponsor":"Amgen","briefTitle":"GLobal Assessment of Plaque reGression With a PCSK9 antibOdy as Measured by intraVascular Ultrasound","officialTitle":"A Double-blind, Randomized, Multi-center, Placebo-controlled, Parallel-group Study to Determine the Effects of Evolocumab (AMG 145) Treatment on Atherosclerotic Disease Burden as Measured by Intravascular Ultrasound in Subjects Undergoing Coronary Catheterization","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-04-18","primaryCompletion":"2016-07-12","completion":"2016-07-29","firstPosted":"2013-03-19","resultsPosted":"2018-01-04","lastUpdate":"2019-02-20"},"enrollment":970,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Hypercholesterolemia"],"interventions":[{"type":"BIOLOGICAL","name":"Evolocumab","otherNames":["AMG 145","RepathaÂ®"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Evolocumab","type":"EXPERIMENTAL"}],"summary":"This study will evaluate whether low-density lipoprotein (LDL-C) lowering with evolocumab (AMG 145) results in greater change from baseline in percent atheroma volume (PAV) at week 78 than placebo in adults with coronary artery disease taking lipid lowering therapy.","primaryOutcome":{"measure":"Change From Baseline in Percent Atheroma Volume at Week 78","timeFrame":"Baseline and week 78","effectByArm":[{"arm":"Placebo","deltaMin":0.053,"sd":0.189},{"arm":"Evolocumab","deltaMin":-0.955,"sd":0.19}],"pValues":[{"comp":"OG000 vs OG001","p":"< 0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":8},"locations":{"siteCount":226,"countries":["United States","Argentina","Australia","Belgium","Brazil","Canada","Chile","Czechia","Denmark","France","Germany","Greece","Hungary","Iceland","Ireland","Israel","Italy","Malaysia","Mexico","Netherlands","Norway","Philippines","Poland","Russia","Singapore","South Africa","South Korea","Spain","Sweden","Switzerland","Taiwan","United Kingdom"]},"refs":{"pmids":["27846344","30336824","33078867","27264224"],"seeAlso":["http://www.amgentrials.com"]},"adverseEventsSummary":{"seriousAny":{"events":142,"n":484},"commonTop":["Hypertension","Myalgia","Chest pain","Angina pectoris","Headache"]}}